Aims: Alzheimer's disease (AD), a progressive development dementia, is increasingly impacting patients' living conditions worldwide. Despite medical care and funding support, there are still no highly individualized drugs and practical strategies for clinical prevention and treatment. Developmentally regulated brain protein (abbreviated as Drebrin or Dbn, also known as Dbn1 in mouse) exists in neurons, especially in dendrites, and is an actin-binding protein that modulates synaptic morphology and longterm memory. However, the majority of previous studies have focused on its upstream proteins and neglected the impact Drebrin has on behavior and AD in vivo. 
| INTRODUCTION
Alzheimer's disease (AD) is a type of degenerative disease with latent clinical characteristics in its early stage. It is an age-related dementia with multiple symptoms, including amnesia, disorientation, aphasia, and agnosia.
1-3 AD has increasingly impacted patients' living quality and places an immense burden on families. With an increasing aging population, the rising incidence of AD patients has caused an increase in medical costs and mortality in patients over 65 years of age. 4, 5 The main pathological characteristics of AD are senile plaques (SP)
that derive from deposits of amyloid β (Aβ)-peptide and neurofibrillary tangles (NFT), which result from the abnormal phosphorylated microtubule-associated protein tau. These pathologies contribute to the final outcome of neuronal and synaptic death. [6] [7] [8] [9] However, synaptic linkage is the foundation of information transmission between neurons at the distal ends of dendrites, and changes to this transmission play an important role in memory. 10, 11 Furthermore, learning and memory impairment observed in AD has a close relationship with hippocampal synaptic damage in its early stage. 12, 13 Developmentally regulated brain protein (abbreviated as Drebrin or Dbn, also known as Dbn1 in mouse)
is distributed in the cytoplasm of neurons, especially in the synapse. It can combine with filamentous actin (F-actin) in the postsynaptic density (PSD) to maintain long-term potentiation (LTP) in the hippocampus.
Drebrin plays an important role in long-term memory 14, 15 and regulates memory activities by combining with or depolymerizing F-actin. [16] [17] [18] In addition, Drebrin also plays a pivotal role in cell migration, synaptogenesis, and synaptic plasticity. 19, 20 Postmortem studies show that Drebrin in the frontal cortex and hippocampus of AD patient brains is significantly lower than in normal brains. 21, 22 This implies that low levels of Drebrin may play a vital role in the clinical and pathological manifestations of AD.
The majority of the studies on Drebrin were conducted on a molecular and cellular level to explore its structure and function.
Furthermore, most in vivo studies concentrate on its effects with upstream proteins but lack research focused on Drebrin's impact on cognitive behavior in AD. 19, 23, 24 In this study, to explore the regularity of age, meticulous behavioral tests were conducted in APP/PS1 mice aged 4-16 months. A correlation analysis between Drebrin levels and behavioral data was performed. We found that Drebrin levels correlate 
| MATERIALS AND METHODS

| Animals
| Behavioral tests
| Morris water maze (MWM) test
The MWM test, which forces rodents to swim and trains them to search for a hidden platform under the water's surface, 25 was used to assess learning and memory capabilities of mice in our study. The apparatus was a white circular pool with a diameter of 100 cm and a height of 50 cm. The pool was imaginarily divided into four equal quadrants that were numbered 1, 2, 3, and 4. The first quadrant was the target quadrant with a cylindrical hidden platform (9 cm diameter, 27 cm height) in its center. The pool was filled with water at 23±1°C
and was made opaque with nonfat milk powder. A flag, which the mice could use to navigate the maze, was positioned above the pool wall at a constant location during testing. A video camera tracked the swimming path of every mouse. All activities were analyzed by Ethovision XT (Noldus, Wageningen, the Netherlands) monitoring analysis software. The test included three phases, including visual platform, hidden platform to start, and probe tests. At the midpoint of the pool wall of the third quadrant, mice were placed in the water and swam with the cue flag. In this stage, mice could board the visual platform for no more than 60 seconds. Each mouse could be guided to board the platform and stand on the platform for 20 seconds. The second stage was conducted over five consecutive days. In this stage, the platform was submerged 1 cm under the water's surface and hidden by opaque milk.
Each mouse was placed in the water from the pool wall in any quadrant except the platform quadrant. If mice explored in the pool and escaped onto the platform for 5 seconds within 60 seconds, the total time was recorded as the escape latency. If the mouse failed to board the platform within 60 seconds, it was guided to the platform by the experimenter and allowed to stand on it for 15 seconds. Each mouse was trained three times daily starting in a different quadrant each trial.
Time intervals between every two quadrant training sessions were not less than 30 minutes. Mice were wiped with a dry towel and dried by a heater after each session. All activities were recorded, including escape latency, success rate (ie, the rate of board on the platform on the fifth day), and swimming trace. The platform was removed on the sixth day, and mice were placed in the water from the middle of the pool wall of the third quadrant and allowed to swim freely for 60 seconds. All activities were recorded, including time spent in the target quadrant, frequency of crossing the target quadrant, swimming trace. All results were analyzed by Ethovision XT monitoring analysis software. 
| Open field test
| Novel object test
A novel object test was used to examine recognition ability because innate curiosity prompts rodents to explore novel objects. The appa- DI=(TN+TF/TN+TF)×100%. 27 The apparatus was cleaned with 75%
alcohol between every two mice tested to eliminate odor. 
| rAAV9-Dbn1 vector production and purification
| Intrahippocampal injections
To perform accurate injections, we injected trypan blue diluent into the hippocampi of mice using a stereotaxic apparatus, which served as a preliminary experiment. The injection coordinates were determined according to The Mouse Brain in stereotaxic coordinates 28 
| Western blot
Hippocampal 
| Immunohistochemical staining
Brains were fixed with 10% formalin solution for 48-72 hours. Brains were then dehydrated, embedded in paraffin, and cut into 4-μm coronal sections. To label with a corresponding antibody, three hippocampal slices from the same anatomical regions of each mouse were processed.
Paraffin sections were dewaxed and rehydrated by gradient alcohol baths.
Sections underwent antigen retrieval in a sodium citrate buffer bath and 
| Immunofluorescence staining
We selected three hippocampal slices from the same anatomical regions 
| Statistical analysis
Statistical analyses were performed by using SPSS 13.0 for windows (SPSS Inc., Chicago, IL). The results are expressed as the means±SEM.
Student's t test was used for two-group analysis. Tukey's test was used for multiple group analysis. The Pearson correlation test was used for correlation analysis. A P value<.05 was considered statistically significant.
| RESULTS
| The expression of Drebrin is downregulated in the hippocampus of aged AD mice compared with that of age-matched WT and young adult AD mice
To observe the regularity of Drebrin expression in APP/PS1 mouse hippocampal tissue, we measured Drebrin expression levels using Western blot in 12-month-old APP/PS1 AD mice and age-matched WT hippocampi ( Figure 1A ,B). The levels of Drebrin in APP/PS1 mice were significantly lower than in the WT group (n=9 per group, P<.01). The data were consistent with the low level of Drebrin measured in AD patient hippocampi compared with age-matched subjects in the human literature. 19 These results imply that Drebrin may be involved in the degeneration of the central nervous system. To confirm the correlation between the expression levels of Drebrin and aging, we detected the expression of the Drebrin protein in the hippocampus of adult APP/PS1 mice at different ages (4, 8, 12 , and 16 months). Drebrin levels in the 16-month group were significantly lower than those in the 4-and 8-month groups (P<.01). Furthermore, Drebrin levels in the 12-month group were significantly lower than those in the 4-month group (P<.01), and the levels in the 8-month group were significantly lower than those in the 4-month group (P<.05) (Figure 1 C,D) . These results indicate that the expression of Drebrin in the hippocampus of AD mice decreases with age.
| Cognitive ability of APP/PS1 mice decreases with age
The MWM is a classic experiment to test the ability of learning and memory in mice by testing their navigation ability to find a hidden platform with respect to landmark cues. In the navigation stage, the escape latency of mice in all groups was shortened with more days of training. The escape latency of AD mice is also generally longer Subsequently, open field and novel object tests were conducted for further study. In the open field test, there was no significant difference in total distance, frequency to the center zone, and frequency of grooming ( Figure 2E,F) . However, the frequency of rearing tends to decrease with age ( Figure 2F ), especially in 16-month-old compared to 4-month-old AD mice (P<.05). In the novel object test, the discrimination index (DI) percentage in 8-, 12-, and 16-month-old AD mice was significantly lower than in 4-month-old mice (P<.05; Figure 2G ). Figure 3C ), indicating that Drebrin has no significant impact on autonomic activities in AD mice. The DI in the novel object test was compared with Drebrin, showing a significant correlation with Drebrin protein levels (r=.757, P<.001) ( Figure 3D ).
| Drebrin protein expression in the hippocampus correlates with behavioral performance in different aged AD mice
This suggests that decreased Drebrin expression may impact memory ability and curiosity.
| Production of AAV9-mDbn1 vectors and expression in the hippocampus of AD mice
To further study the role of Drebrin in the central nervous system of AD mice, AAV9-mDbn1 was produced by the connection between a 
| Cognitive ability improved significantly in APP/ PS1-Dbn1 mice
The escape latency of mice in all groups was shortened with increased days of training in the navigation stage of MWM. An escape latency scatter plot shows that there are no significant differences between the control and APP/PS1 groups, but the APP/PS1-Dbn1 group did spend less time than the two groups (P<.05). On the last day of training, the success rate of finding the platform showed that the control group mice were significantly slower than the APP/PS1-Dbn1 mice (P<.05; Figure 5A ). In the probe test, the time spent in the target quadrant and the frequency of crossing the platform area in all groups of mice also showed different performances. APP/PS1-Dbn1 mice spent significantly more time in the target quadrant and had a significantly greater frequency of crossing the platform area than the control group mice (P<.05; Figure 5B ). The data show that the learning, memory, and spatial localization ability of APP/PS1-Dbn1 mice improved significantly. The open field and novel object tests were performed for further study. There were no significant differences in total distance, frequency to the center zone, and frequency of grooming between groups in the open field test (Figure 5E,F) . Nevertheless, the frequency of rearing in APP/PS1-Dbn1 mice was significantly higher than in the control group (P<.05) and there was no significant difference in WT mice (P>.05; Figure 5F ). In the novel object test, the DI in APP/PS1-Dbn1 mice was significantly higher than in control and APP/ PS1 mice (P<.05; Figure 5G ). All results suggest that AAV9-Dbn1 vectors in the hippocampus can promote better performance in AD mice than non-Dbn1 AD mice in MWM, open field, and novel object tests.
The improved behavioral performance of APP/PS1-Dbn1 mice may be due to high levels of the Drebrin protein. increases with age and is aggravated in AD patients. 29 Similarly, the same lesions and features also exist in the brains of APP/PS1 mice.
| The expression level of Drebrin in APP/
30
The anti-Aβ17-24 antibody was used to detect Aβ plaques in immu- Figure 6C,F) . Furthermore, the control group
(F)
had significantly more astrocytes than the other three groups. These findings suggest that operative injury activates astrocytes, but high levels of Drebrin may inhibit over activated astrocytes.
| Relative protein changes of Drebrin in APP/ PS1-Dbn1 mice
The immunofluorescence assays to detect F-actin, NMDAR1, MAP-2, and Syn1 were performed to investigate the impact of increased 
| DISCUSSION
In this study, the results suggest that effective expression of the Finally, the novel object test was conducted to detect recognition ability to novel objects. 44, 45 We found a significant difference in all three tests, especially in MWM and novel object tests. These data show a significant decline in cognitive and autonomous activities with age. The correlation analysis data showed that the expres- Accumulative Aβ in AD activates glial cells and produces various inflammatory factors to aggravate neurotoxicity, which contributes to synaptic depression and cognitive impairment. [47] [48] [49] We found that the area fraction and number of plaques of Aβ in the hippocampus of APP/PS1-Dbn1 mice are significantly reduced. Cell research showed that the Aβ42 oligomer can reduce Drebrin in hippocampal neurons
The behavioral performance of mice in different groups (WT, APP/PS1, control, and APP/PS1-Dbn1 We suggest that Drebrin may play a role in inhibiting Aβ generation or accelerating its degradation. Astrocytes, distributed widely in the brain to maintain homeostasis, provide nutrition, regulates energy metabolism, and transduces signals, among other duties. 51 However, astrocyte reactivity increases and reactive gliosis are main factors of neuroplasticity and CNS regeneration when cerebral injury occurs.
52
Activated astrocytes can increase Aβ by secreting inflammatory factors and complements. 53, 54 GFAP is a specific marker of astrocytes, which modulates the morphology and quantity of astrocytes to be used to evaluate cerebral status. We found that GFAP in an injection area increased the quantity and changed the morphology in the control group, implying that astrocytes were activated by injection and vector stimulation. Conversely, there are rarely activated astrocytes in the APP/PS1-Dbn1 group, in which the quantity was close to the APP/ PS1 group. These results suggest that effective expression of Drebrin may inhibit the activation of astrocytes.
Drebrin regulates memory by binding or depolymerization with F-actin, which interacts with neural microtubules mediated by Drebrin. 55 In addition, the distribution of F-actin was also adjusted by Drebrin. 56 We found that increased levels of Drebrin can promote an increase in the quantity of F-actin. MAP-2 is distributed in the neuronal cytoplasm, especially in dendrites. It can adjust microtubule assembly and stabilize the cytoskeleton to maintain neuron dendritic growth. [57] [58] [59] In this study, MAP-2 in the APP/PS1-Dbn1 group was significantly higher than in the control group in the hippocampus. We suggest that increased levels of Drebrin can stabilize neuronal dendrites to improve cognitive function. Thus, rAAV9-mediated effective expression of Drebrin in the hippocampus of AD model mice may provide a valid method to improve cognitive ability by inhibiting Aβ.
| CONCLUSION
Our study showed that hippocampal Drebrin protein expression levels in adult APP/PS1 mice decline with age. Furthermore, our behavioral data demonstrated that cognitive and probe activities decline with age. A correlation analysis showed that the expression level of the Drebrin protein significantly correlatives with behavioral performance in AD mice. rAAV9-Dbn1 vectors can maintain an effective expression level of Drebrin, which improves performance and alleviates lesions in AD mice. These results may provide some valid resources for therapy and research of AD.
